AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

RBC Life Sciences, Inc.

$0 +$0.00 (+75.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
1.55K
AVG Volume
1.92K
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
02M4M6M8M15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Revenue (USD) by quarter
PeriodRevenue (USD)
17 Q34.9M
17 Q25.74M
17 Q15.7M
16 Q47.26M
16 Q37.33M
16 Q25.99M
16 Q15.2M
15 Q47.41M
15 Q35.41M
15 Q26.19M
Net Income (USD)
-600K-400K-200K0200K400K15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Net Income (USD) by quarter
PeriodNet Income (USD)
17 Q3-350.41K
17 Q2-114.97K
17 Q145.85K
16 Q4-270.75K
16 Q3106.65K
16 Q2-182.97K
16 Q1-409.21K
15 Q4-276.97K
15 Q3330.75K
15 Q2-245.63K
Operating Income (USD)
-2M-1M01M15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Operating Income (USD) by quarter
PeriodOperating Income (USD)
17 Q3-356.8K
17 Q2-176K
17 Q1-39.36K
16 Q4-217.69K
16 Q3294.03K
16 Q2-219.38K
16 Q1-523.25K
15 Q4-1.99M
15 Q3562.01K
15 Q2-305.36K
EBITDA (USD)
-500K0500K1M15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL EBITDA (USD) by quarter
PeriodEBITDA (USD)
17 Q3-270K
17 Q2-111.77K
17 Q155.51K
16 Q4-125.61K
16 Q3398.4K
16 Q2-108.62K
16 Q1-411.82K
15 Q4-174.71K
15 Q3691.95K
15 Q2-155.98K
Cash Flows (USD)
-3M-2M-1M01M15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Cash Flows (USD) by quarter
PeriodCash Flows (USD)
17 Q3-92.85K
17 Q2182.38K
17 Q1-591.45K
16 Q430.54K
16 Q3556.06K
16 Q2-9.4K
16 Q1-570.49K
15 Q4-661.84K
15 Q3-2.9M
15 Q226.55K
EPS (USD)
-0.2-0.100.10.215 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL EPS (USD) by quarter
PeriodEPS (USD)
17 Q3-0.16
17 Q2-0.05
17 Q10.02
16 Q4-0.12
16 Q30.05
16 Q2-0.08
16 Q1-0.18
15 Q4-0.13
15 Q30.15
15 Q2-0.11
Expenses (USD)
-2M02M4M6MSG&ACapex15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Expenses (USD) by quarter
PeriodExpenses (USD)
17 Q32.91M
17 Q23.37M
17 Q13.06M
16 Q43.83M
16 Q33.52M
16 Q23.54M
16 Q13.14M
15 Q43.96M
15 Q34.28M
15 Q23.67M
Cash & Debt (USD)
01M2M3MCashLong Term DebtShort Term Debt15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
17 Q3685.43K
17 Q2727.29K
17 Q1650.38K
16 Q41.47M
16 Q31.3M
16 Q2786.53K
16 Q1757.6K
15 Q41.45M
15 Q32.09M
15 Q2915.05K
Debt ratios
-100010020030015 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Debt ratios by quarter
PeriodDebt ratios
17 Q31.52
17 Q2-3.36
17 Q1-2.96
16 Q45.94
16 Q34.37
16 Q2245.64
16 Q114.98
15 Q44.79
15 Q323.97
15 Q2-0.16
Margins
0%20%40%60%15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Margins by quarter
PeriodMargins
17 Q351.79%
17 Q256.45%
17 Q153.36%
16 Q449.49%
16 Q353.28%
16 Q255.43%
16 Q152.32%
15 Q451.16%
15 Q357.77%
15 Q256.52%
Return on Capital
-7.5%-5%-2.5%0%2.5%5%15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Return on Capital by quarter
PeriodReturn on Capital
17 Q3-5.33%
17 Q2-1.66%
17 Q10.65%
16 Q4-3.8%
16 Q31.46%
16 Q2-2.53%
16 Q1-5.53%
15 Q4-3.51%
15 Q34.11%
15 Q2-3.25%
Shares Outstanding
01M2M3M15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Shares Outstanding by quarter
PeriodShares Outstanding
17 Q32.21M
17 Q22.21M
17 Q12.21M
16 Q42.21M
16 Q32.21M
16 Q22.21M
16 Q12.21M
15 Q42.21M
15 Q32.21M
15 Q22.21M
Book Value Per Share (USD)
0123415 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
17 Q32.97
17 Q23.12
17 Q13.18
16 Q43.22
16 Q33.29
16 Q23.27
16 Q13.34
15 Q43.56
15 Q33.63
15 Q23.42
Total Assets (USD)
05M10M15M15 Q215 Q315 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q3
RBCL Total Assets (USD) by quarter
PeriodTotal Assets (USD)
17 Q311.85M
17 Q212.29M
17 Q111.51M
16 Q410.96M
16 Q311.21M
16 Q211.31M
16 Q110.87M
15 Q411.3M
15 Q312.83M
15 Q214.86M
PE Ratio
0100200300med 31.72Jan 10Jul 10Feb 11May 11Sep 11Dec 11Dec 12
RBCL PE Ratio by quarter
PeriodPE Ratio
Dec 12166.37
Dec 12166.37
Dec 12236.82
Dec 12236.82
Nov 12236.82
Nov 12236.82
Nov 1215.39
Nov 12288.63
Nov 1247.36
Oct 1221.15
Oct 1231.72
Oct 1231.72
Oct 1231.72
Sep 1231.72
Dec 1118.99
Dec 1118.99
Dec 1119.92
Dec 1119.92
Nov 1120.85
Nov 1120.38
Nov 1123.7
Nov 1120.85
Oct 1123.7
Oct 1121.84
Oct 1122.77
Oct 1119.05
Sep 1126.56
Sep 1116.2
Sep 1114.93
Sep 1115.57
Sep 1115.57
Aug 1114.93
Aug 1115.57
Aug 1119.47
Aug 1118.16
Jul 1118.16
Jul 1116.2
Jul 1118.79
Jul 1119.47
Jul 1119.47
Jun 1116.89
Jun 1117.99
Jun 1119.14
Jun 1117.99
May 1116.89
May 1114.06
May 1119.69
May 1116.89
Apr 1115.2
Apr 1115.2
Apr 1115.2
Apr 1118.54
Apr 1118.54
Mar 1148.14
Mar 1148.14
Mar 1148.14
Mar 1135.72
Feb 1135.72
Feb 1141.3
Feb 1138.51
Feb 1141.3
Jan 1138.51
Jan 1141.3
Jan 1139.19
Jan 1141.3
Dec 1038.51
Sep 10244.39
Sep 10250.86
Sep 10204.66
Sep 10171.4
Aug 10164.93
Aug 10250.86
Aug 10244.39
Aug 10257.33
Jul 10257.33
Jul 10244.39
Jul 10250.86
Jul 10231
Jul 10191.26
Mar 1084.35
Mar 1092.85
Mar 1092.85
Mar 1081.04
Feb 1084.35
Feb 1067.57
Feb 1084.35
Feb 1070.88
Jan 1067.57
Jan 1091.2
Jan 1084.35
Jan 1084.35
Dec 0972.53
Dec 095.75
Dec 095.75
Dec 096.81
Dec 096.61
Nov 096.45
Nov 098.04
Nov 097.18
Nov 099.47
Free Cash Flow Yield
-400000%-300000%-200000%-100000%0%med -158699.21%Jan 25May 25Sep 25Jan 26May 26Sep 26
RBCL Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-30429.27%
Sep 26-30429.27%
Aug 26-30429.27%
Aug 26-30429.27%
Aug 26-30429.27%
Aug 26-30429.27%
Jul 26-30429.27%
Jul 26-30429.27%
Jul 26-30429.27%
Jul 26-30429.27%
Jul 26-30429.27%
Jun 26-30429.27%
Jun 26-30429.27%
Jun 26-30429.27%
Jun 26-30429.27%
May 26-30429.27%
May 26-30429.27%
May 26-30429.27%
May 26-30429.27%
May 26-30429.27%
Apr 26-30429.27%
Apr 26-30429.27%
Apr 26-30429.27%
Apr 26-30429.27%
Mar 26-30429.27%
Mar 26-35500.82%
Mar 26-35500.82%
Mar 26-35500.82%
Feb 26-35500.82%
Feb 26-35500.82%
Feb 26-35500.82%
Feb 26-35500.82%
Jan 26-35500.82%
Jan 26-35500.82%
Jan 26-35500.82%
Jan 26-53251.23%
Jan 26-53251.23%
Dec 25-53251.23%
Dec 25-53251.23%
Dec 25-106502.46%
Dec 25-106502.46%
Nov 25-106502.46%
Nov 25-106502.46%
Nov 25-106502.46%
Nov 25-106502.46%
Oct 25-106502.46%
Oct 25-106502.46%
Oct 25-106502.46%
Oct 25-106502.46%
Oct 25-106502.46%
Sep 25-213004.92%
Sep 25-213004.92%
Sep 25-213004.92%
Sep 25-213004.92%
Aug 25-213004.92%
Aug 25-213004.92%
Aug 25-213004.92%
Aug 25-213004.92%
Aug 25-213004.92%
Jul 25-213004.92%
Jul 25-213004.92%
Jul 25-213004.92%
Jul 25-213004.92%
Jun 25-213004.92%
Jun 25-213004.92%
Jun 25-213004.92%
Jun 25-213004.92%
May 25-213004.92%
May 25-213004.92%
May 25-213004.92%
May 25-213004.92%
May 25-213004.92%
Apr 25-213004.92%
Apr 25-213004.92%
Apr 25-213004.92%
Apr 25-213004.92%
Mar 25-213004.92%
Mar 25-213004.92%
Mar 25-213004.92%
Mar 25-213004.92%
Feb 25-213004.92%
Feb 25-210895.95%
Feb 25-304292.72%
Feb 25-304292.72%
Jan 25-304292.72%
Jan 25-304292.72%
Jan 25-304292.72%
Jan 25-304292.72%
Jan 25-304292.72%
Dec 24-304292.72%
Dec 24-304292.72%
Dec 24-304292.72%
Dec 24-304292.72%
Nov 24-304292.72%
Nov 24-304292.72%
Nov 24-304292.72%
Dec 23-213004.91%
Dec 23-213004.91%
Nov 23-213004.91%
Nov 23-213004.91%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RBCL Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Dec 230
Dec 230
Nov 230
Nov 230
EV/EBITDA
-10-50510med -0.09Oct 12Jan 13May 13Aug 13Feb 14Sep 17Dec 17
RBCL EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 17-1.72
Dec 17-1.72
Dec 17-2.03
Dec 17-0.82
Nov 17-0.82
Nov 17-0.82
Nov 17-0.82
Nov 17-1.31
Oct 17-1.42
Oct 17-1.42
Oct 17-1.52
Oct 17-1.31
Sep 17-1.47
Sep 17-0.34
Sep 170.36
Sep 170.36
Sep 17-0.09
Aug 17-0.09
Aug 17-0.09
Aug 17-0
Aug 17-0
Jul 17-0
Jul 17-0.14
Jul 17-0.14
Jul 17-0.14
Jun 17-0.14
Mar 14-4.01
Mar 14-4.01
Mar 14-3.3
Mar 14-3.3
Feb 14-2.82
Feb 14-3.89
Feb 14-5.68
Feb 14-3.42
Jan 14-2.4
Jan 14-2.4
Jan 14-2.4
Jan 14-2.4
Jan 14-2.4
Sep 132.12
Sep 132.12
Sep 132.15
Sep 132.15
Aug 132.15
Aug 130.55
Aug 13-0.09
Aug 132.8
Aug 132.47
Jul 132.47
Jul 132.47
Jul 132.47
Jul 132.47
Jun 132.1
Jun 132.1
Jun 132.1
Jun 132.1
May 132.1
May 13-1
May 130.55
May 130.2
May 132.1
Apr 132.49
Apr 132.49
Apr 131.33
Apr 133.26
Mar 134.43
Mar 134.43
Mar 134.43
Mar 135.63
Mar 135.63
Feb 135.63
Feb 135.23
Feb 135.23
Feb 133.22
Jan 132.02
Jan 132.02
Jan 132.02
Jan 132.02
Dec 121.66
Dec 121.66
Dec 123.47
Dec 123.47
Nov 123.47
Nov 123.47
Nov 12-2.21
Nov 124.8
Nov 12-1.39
Oct 12-2.07
Oct 12-1.79
Oct 12-1.79
Oct 12-1.79
Sep 12-1.79
Sep 12-2.69
Sep 12-4.29
Sep 12-4.29
Aug 12-4.62
Aug 12-6.21
Aug 12-4.29
Aug 12-3.33
Aug 12-3.33
Price/Operating Cashflow
05101520med 3.56Oct 13Jan 14May 14Nov 14May 17Sep 17Dec 17
RBCL Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Dec 171.19
Dec 171.19
Dec 170.96
Dec 171.84
Nov 171.84
Nov 171.84
Nov 171.84
Nov 171.48
Oct 171.41
Oct 171.41
Oct 171.33
Oct 171.48
Sep 171.37
Sep 172.93
Sep 173.71
Sep 173.71
Sep 173.21
Aug 173.21
Aug 173.21
Aug 173.31
Aug 173.31
Jul 173.31
Jul 173.15
Jul 173.15
Jul 173.15
Jun 173.15
Jun 173.98
Jun 173.98
Jun 173.98
Jun 173.98
May 173.98
May 173.84
May 174.7
May 174.27
Apr 173.56
Apr 173.56
Apr 173.56
Apr 173.56
Mar 173.56
Dec 1414.86
Dec 1414.86
Dec 1415.45
Dec 1415.45
Nov 1415.45
Nov 1415.45
Nov 1416.64
Nov 1416.64
Oct 1416.64
Oct 1416.64
Oct 1417.83
Oct 1417.83
Oct 1419.61
Jun 145.65
Jun 145.65
Jun 144.52
Jun 144.52
May 144.15
May 144.52
May 144.52
May 143.47
May 145.65
Apr 145.65
Apr 145.65
Apr 145.65
Apr 147.54
Mar 141.76
Mar 141.76
Mar 141.93
Mar 141.93
Feb 142.04
Feb 141.79
Feb 141.38
Feb 141.9
Jan 142.13
Jan 142.13
Jan 142.13
Jan 142.13
Jan 142.13
Dec 1312.64
Dec 1314.49
Dec 1315.56
Dec 1315.56
Nov 1314.59
Nov 1316.24
Nov 1316.24
Nov 1316.24
Nov 1316.24
Oct 1313.62
Oct 1314.59
Oct 1314.49
Oct 1314.49
Sep 133.03
Sep 133.03
Sep 133.05
Sep 133.05
Aug 133.05
Aug 132.03
Aug 131.63
Aug 133.46
Aug 133.26
Price to Book
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RBCL Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Dec 230
Dec 230
Nov 230
Nov 230
RBC Life Sciences, Inc.
RBCL
Stockpicker

Video analysis: RBCL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.